These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8851453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. History of macrolide use in pediatrics.
    Klein JO.
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [Abstract] [Full Text] [Related]

  • 3. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S, Enzler MJ.
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [Abstract] [Full Text] [Related]

  • 4. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH.
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dirithromycin: a new macrolide.
    Wintermeyer SM, Abdel-Rahman SM, Nahata MC.
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [Abstract] [Full Text] [Related]

  • 7. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ, Abruzzo GK, Flattery AM, Smith JG, Jackson J, Kong L, Wilkening R, Shankaran K, Kropp H, Bartizal K.
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH, Friedel HA, McTavish D.
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC, Danziger LH, Rodvold KA.
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [Abstract] [Full Text] [Related]

  • 12. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM, Kaye KM.
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [Abstract] [Full Text] [Related]

  • 13. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA.
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [Abstract] [Full Text] [Related]

  • 14. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
    Jones RN, Doern GV, Gerlach EH, Hindler J, Erwin ME.
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of macrolides against intracellular Legionella pneumophila.
    Segreti J, Meyer P, Kapell K.
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.
    Metzler K, Drlica K, Blondeau JM.
    J Antimicrob Chemother; 2013 Mar; 68(3):631-5. PubMed ID: 23169894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.